Hims & Hers Health, Inc. (HIMS) intrinsic value & 10-year financials
Hims & Hers Health, Inc. (HIMS) has a Graham intrinsic value of $16.94 per share. At $28.07 on Oct 17, 2026, the stock trades 66% above that value. Over the last 8 fiscal years revenue grew 74.7% a year to $2.3B, with an average return on invested capital of 5.2%.
- Graham intrinsic value
- $16.94
- Share price (Oct 17, 2026)
- $28.07
- Price vs Graham value
- 66% above
- Market cap
- $7.2B
- Revenue (FY2025)
- $2.3B
- Revenue growth (8-yr CAGR)
- 74.7%
- ROIC (10-yr avg)
- 5.2%
- Free cash flow (FY2025)
- $57.4M
HIMS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.3B | $128.4M | $0.51 | $57.4M | 4.5% | 29.3% |
| FY2024 | $1.5B | $126.0M | $0.53 | $198.3M | 4.2% | 23.7% |
| FY2023 | $872.0M | -$23.5M | -$0.11 | $47.0M | -3.4% | -11.2% |
| FY2022 | $526.9M | -$65.7M | -$0.32 | -$33.7M | -13.0% | -25.6% |
| FY2021 | $271.9M | -$107.7M | -$0.58 | -$35.2M | -42.3% | -82.5% |
| FY2020 | $148.8M | -$3.0M | -$0.51 | -$2.5M | -3.2% | -121.6% |
| FY2019 | $82.6M | -$72.1M | -$2.07 | -$75.2M | -90.1% | 224.3% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Hims & Hers Health, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Hims & Hers Health, Inc. has historically struggled to out-earn its cost of capital, averaging just -31.3% ROIC.
Hims & Hers Health, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Hims & Hers Health, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $16.94 per share.